Occlutech Grabs CE Mark for Atrial Flow Regulator
Occlutech’s atrial flow regulator device has been cleared on the European market for treating heart failure symptoms through decompression.
The intra-atrial shunt is placed in the patient’s septum between the left and right atriums via a minimally invasive procedure to decompress abnormal pressure.
The device improves heart function by “maintaining the correct sizing of a created shunt,” the company said. The device comes in a variety of sizes to allow individualized treatment.